| 1 |
Photodynamic Therapy for Retinal Hemangioblastoma: Treatment Outcomes of 17 Consecutive Patients |
|
| | Maura Di Nicola, Basil K. Williams, Jing Hua, Vladislav P. Bekerman, Arman Mashayekhi, Jerry A. Shields, Carol L. Shields | | | Ophthalmology Retina. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Intravitreous treatment of severe ocular von
Hippel–Lindau
disease using a combination of the
VEGF
inhibitor, ranibizumab and
PDGF
inhibitor,
E10030
|
|
| | Christopher K. Hwang, Emily Y. Chew, Catherine A. Cukras, Tiarnan D. L. Keenan, Wai T. Wong, W. Marston Linehan, Prashant Chittiboina, Karel Pacak, Henry E. Wiley | | | Clinical & Experimental Ophthalmology. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Clinical use of photodynamic therapy in ocular tumors |
|
| | Eren Cerman,Osman Çekiç | | | Survey of Ophthalmology. 2015; 60(6): 557 | | | [Pubmed] [Google Scholar] [DOI] | |
|
